VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13 | +44.4% | 106,526 | +28.4% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 82,989 | +8.8% | 0.00% | – |
| Q3 2022 | $12,000 | -20.0% | 76,279 | +345.6% | 0.00% | – |
| Q2 2022 | $15,000 | -65.9% | 17,119 | -51.8% | 0.00% | – |
| Q1 2022 | $44,000 | +4.8% | 35,546 | +65.8% | 0.00% | -100.0% |
| Q4 2021 | $42,000 | -46.2% | 21,435 | -23.9% | 0.00% | -50.0% |
| Q3 2021 | $78,000 | +1460.0% | 28,155 | +1773.3% | 0.00% | – |
| Q2 2021 | $5,000 | -94.7% | 1,503 | -96.6% | 0.00% | -100.0% |
| Q1 2021 | $95,000 | +630.8% | 44,571 | +135.3% | 0.00% | – |
| Q3 2020 | $13,000 | +116.7% | 18,943 | +55.5% | 0.00% | – |
| Q2 2020 | $6,000 | +500.0% | 12,179 | +2003.5% | 0.00% | – |
| Q2 2017 | $1,000 | – | 579 | +509.5% | 0.00% | – |
| Q2 2016 | $0 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |